FDA advisers divided on Sanofi’s oral type 1 diabetes drugThe future of Sanofi and Lexicon’s oral diabetes drug Zynquista hangs in the balance after an FDA advisory Share XFDA advisers divided on Sanofi’s oral type 1 diabetes drughttps://pharmaphorum.com/news/fda-divided-on-sanofis-oral-type-1-diabetes-drug/
Novartis and Oxford University begin R&D tie-upNovartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how Share XNovartis and Oxford University begin R&D tie-uphttps://pharmaphorum.com/news/novartis-and-oxford-university-begin-rd-tie-up/
J&J partners with Apple for ECG monitoring projectApple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG) Share XJ&J partners with Apple for ECG monitoring projecthttps://pharmaphorum.com/news/jj-partners-with-apple-for-ecg-monitoring-project/
Brexit and beyond: the challenges ahead for pharmaBrexit, and the political fallout from approving any deal, will continue to dominate British politics in 2019. It Share XBrexit and beyond: the challenges ahead for pharmahttps://pharmaphorum.com/views-analysis-sales-marketing/brexit-challenges-ahead-pharma/
Women in Science: AstraZenecaWe speak to three of AstraZeneca’s senior leaders about their careers, the future of their therapy areas and Share XWomen in Science: AstraZenecahttps://pharmaphorum.com/r-d/views-analysis-r-d/women-in-science-astrazeneca/
Young advocate’s patient voice heard at top levels of powerListening to the patient voice gives industry the opportunity to learn about the challenges people with long-term conditions Share XYoung advocate’s patient voice heard at top levels of powerhttps://pharmaphorum.com/views-analysis-patients/young-advocates-patient-voice/
Deep Dive: Disruptive TechnologiesIn the first issue of Deep Dive for 2019, we look at disruptive technologies in pharma, how they’re Share XDeep Dive: Disruptive Technologieshttps://pharmaphorum.com/digital/disruptive-technologies-pharma-2019/
European digital health innovationHealthcare and the pharmaceutical industry are redefining their roles for the modern age as digital health tech radically Share XEuropean digital health innovationhttps://pharmaphorum.com/digital/european-digital-health-innovation/
CAR-Ts – a new weapon in the fight against cancerCAR-T – or Chimeric Antigen Receptor T-cell therapies herald a new wave of therapies in cancer. CAR-T therapies Share XCAR-Ts – a new weapon in the fight against cancerhttps://pharmaphorum.com/views-and-analysis/car-ts-a-new-weapon-in-the-fight-against-cancer/
Cancer, genomics and personalised medicine: Modelling oncology’s future Share XCancer, genomics and personalised medicine: Modelling oncology’s futurehttps://pharmaphorum.com/oncology/cancer-genomics-and-personalised-medicine-modelling-the-future-of-oncology/
Metrics to meaning: demonstrating the value of medical communications Share XMetrics to meaning: demonstrating the value of medical communicationshttps://pharmaphorum.com/sales-marketing/metrics-to-meaning-demonstrating-the-value-of-medical-communications/
The devil’s in the e-detail: what HCPs really want from you Share XThe devil’s in the e-detail: what HCPs really want from youhttps://pharmaphorum.com/digital/the-devils-in-the-e-detail-what-hcps-really-want-from-you/
Protected: Designing behavioural science-based patient support programmesThere is no excerpt because this is a protected post. Share XProtected: Designing behavioural science-based patient support programmeshttps://pharmaphorum.com/sales-marketing/designing-behavioural-science-based-patient-support-programmes/
Adherence – Don’t Remind Me!The benefits of adherent patients are no secret: better outcomes, a more stable treatment pathway and of course Share XAdherence – Don’t Remind Me!https://pharmaphorum.com/sales-marketing/adherence-dont-remind-me/
Intelligent HCP engagement in Europe – what do doctors want?The opportunity to engage with HCPs digitally has never been more prevalent. We are witnessing a desire from Share XIntelligent HCP engagement in Europe – what do doctors want?https://pharmaphorum.com/digital/intelligent-hcp-engagement-europe/
Biotech strategy and nanomedicine: the pharmaphorum podcast Share XBiotech strategy and nanomedicine: the pharmaphorum podcasthttps://pharmaphorum.com/r-d/biotech-strategy-and-nanomedicine/
The future of pharma in a digital world Share XThe future of pharma in a digital worldhttps://pharmaphorum.com/digital/healthlive-the-future-of-pharma-in-a-digital-world/
Raising the bar in liver cancer therapy Share XRaising the bar in liver cancer therapyhttps://pharmaphorum.com/oncology/insights-oncology/raising-bar-liver-cancer-therapy/
Pharmaceutical Microbiology UK CONFEX takes place in less than a week! Share XPharmaceutical Microbiology UK CONFEX takes place in less than a week!https://pharmaphorum.com/partner-content/pharmaceutical-microbiology-uk-confex-takes-place-in-less-than-a-week/
Tom Parke to lead a workshop on the new FDA draft guidance Share XTom Parke to lead a workshop on the new FDA draft guidancehttps://pharmaphorum.com/partner-content/tom-parke-to-lead-a-workshop-on-the-new-fda-draft-guidance/
Join Pharmaceutical Social Media Experts in Just 1 Week! Share XJoin Pharmaceutical Social Media Experts in Just 1 Week!https://pharmaphorum.com/partner-content/join-pharmaceutical-social-media-experts-in-just-1-week-2/
Three-dimensional cell cultures as predictive tools in early drug discovery Share XThree-dimensional cell cultures as predictive tools in early drug discoveryhttps://pharmaphorum.com/partner-content/three-dimensional-cell-cultures-as-predictive-tools-in-early-drug-discovery/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
